Security Snapshot

Fresenius Medical Care AG - Ordinary Shares without par value (FMS) Institutional Ownership

CUSIP: 358029106

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

132

Shares (Excl. Options)

32.44MFull value: 32,440,517 · shares · 30 Sep 2026

Price

$22.38

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Ordinary Shares without par value
Symbol
FMS on NYSE
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
32,440,517
Latest holder snapshot 5 signals
Total 13F value
$725,942,551
Portfolio coverage rank
0%
Share change
+274,644
Value change
+$5,415,961
Number of holders
132
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
257,120,182
SEC-reported price per share
$21.21
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • FMS - Fresenius Medical Care AG - Ordinary Shares without par value is tracked under CUSIP 358029106.
  • 132 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 236 to 132 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $960.46MFull value: $960,455,566 · USD · 30 Jun 2026
    to
    $725.94MFull value: $725,942,551 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 132 institutions filings for Q3 2026.

Open SEC evidence

Security key

358029106

13F reference period

Q3 2026

13F holders

132

13D/G owners

2

CIK / CUSIP context first

Open Q3 2026 holders FMS full holder history Fresenius Medical Care AG SEC filings Fresenius Medical Care AG company facts Fresenius Medical Care AG insider transactions Fresenius Medical Care AG 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
FMS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fresenius SE & Co. KGaA 21% -18% $1,139,785,483 -$285,131,120 53,738,118 -20% Fresenius SE & Co. KGaA 11 Nov 2026
HARRIS ASSOCIATES L P 3.9% $283,213,788 11,717,575 HARRIS ASSOCIATES L P 31 Dec 2024
As of 30 Sep 2026, 132 institutional investors reported holding
32.44MFull value: 32,440,517 · shares · 30 Sep 2026
shares of Fresenius Medical Care AG - Ordinary Shares without par value (FMS). This represents 13% of the company’s total
257.12MFull value: 257,120,182 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
12%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PZENA INVESTMENT MANAGEMENT LLC 6.5% 16,617,575 +11% 1.1% $371,901,339
MORGAN STANLEY 1.7% 4,424,999 +1.8% 0.01% $99,031,515
Dodge & Cox 1.3% 3,328,110 -13% 0.04% $74,483,102
TODD ASSET MANAGEMENT LLC 0.69% 1,761,483 +35% 0.71% $39,422,198
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 0.43% 1,106,400 +36% 0.17% $24,761,000
ABC ARBITRAGE SA 0.25% 630,995 +163% 1.4% $14,121,668
Quantinno Capital Management LP 0.21% 541,357 +2.5% 0.01% $12,115,585
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.19% 476,268 +612% 0% $10,658,878
Moran Wealth Management, LLC 0.15% 381,352 +5.2% 0.23% $8,534,658
RAYMOND JAMES FINANCIAL INC 0.13% 343,945 -5.7% 0% $7,697,500
Creative Planning 0.13% 337,805 +14% 0% $7,560,073
Qube Research & Technologies Ltd 0.13% 327,927 0.01% $7,339,006
ASSETMARK, INC 0.08% 205,424 +13% 0.01% $4,597,379
NIA IMPACT ADVISORS, LLC 0.06% 145,883 +6.7% 1.4% $3,264,860
RITHOLTZ WEALTH MANAGEMENT 0.05% 135,135 +5.2% 0.04% $3,024,322
BNP PARIBAS FINANCIAL MARKETS 0.04% 112,498 0% $2,517,705
Tidal Investments LLC 0.04% 107,878 +8.1% 0.01% $2,414,310
STIFEL FINANCIAL CORP 0.04% 97,912 +2.9% 0% $2,191,277
SEARLE & CO. 0.03% 80,725 0% 0.43% $1,806,626
Crossmark Global Holdings, Inc. 0.02% 63,752 +10% 0.02% $1,426,770
AMERICAN CENTURY COMPANIES INC 0.02% 61,694 +59% 0% $1,380,712
BAROMETER CAPITAL MANAGEMENT INC. 0.02% 58,200 0% 0.38% $1,302,516
LPL Financial LLC 0.02% 57,402 +0.9% 0% $1,284,656
Cerity Partners LLC 0.02% 49,745 +13% 0% $1,113,300
Orion Porfolio Solutions, LLC 0.02% 44,005 +57% 0.01% $984,841

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 32,440,517 $725,942,551 +$5,415,961 $22.38 132
2026 Q2 42,477,052 $960,455,566 +$15,144,900 $22.61 236
2026 Q1 42,110,804 $949,965,201 +$95,372,319 $22.56 219
2025 Q4 37,508,073 $893,440,267 +$33,309,792 $23.82 213
2025 Q3 36,120,634 $951,005,129 -$14,569,100 $26.33 203
2025 Q2 36,636,431 $1,046,674,202 +$46,295,068 $28.57 203
2025 Q1 35,046,889 $872,643,678 +$27,257,295 $24.90 197
2024 Q4 34,017,350 $770,139,012 +$5,191,746 $22.64 187
2024 Q3 33,465,497 $713,210,489 +$46,953,355 $21.30 164
2024 Q2 31,332,670 $598,145,446 -$36,538,124 $19.09 166
2024 Q1 33,213,535 $640,484,181 -$410,800 $19.28 168
2023 Q4 33,129,394 $689,882,206 -$1,429,220 $20.83 160
2023 Q3 33,054,027 $711,494,307 -$24,576,102 $21.54 146
2023 Q2 34,074,546 $815,697,393 -$113,386,403 $23.93 141
2023 Q1 38,943,140 $828,079,836 -$106,128,012 $21.26 147
2022 Q4 44,147,684 $721,518,359 +$190,854,706 $16.34 151
2022 Q3 32,612,977 $457,762,115 -$40,450,898 $14.04 133
2022 Q2 32,237,246 $803,829,195 +$52,339,396 $24.94 155
2022 Q1 30,584,664 $1,030,101,462 +$97,919,185 $33.68 173
2021 Q4 27,697,563 $899,187,170 +$54,237,214 $32.46 165
2021 Q3 25,876,821 $905,133,412 +$190,668,853 $34.97 150
2021 Q2 20,356,867 $846,033,789 +$44,454,274 $41.57 168
2021 Q1 19,343,763 $713,592,444 +$321,140,390 $36.88 162
2020 Q4 10,477,415 $435,514,087 +$61,869,042 $41.56 169
2020 Q3 9,057,592 $384,729,746 +$298,263 $42.48 175
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .